ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1341	National Cancer Institute	Html	en	Smokeless Tobacco and Cancer	A fact sheet about the health risks associated with the use of smokeless tobacco.	tobacco cut size 0.465919 NCI smoking cessation 0.353151 safe level 0.345736 oral tobacco 0.470575 nicotine addiction 0.363201 Human Services 0.340767 Health State-of-the-Science conference 0.343313 U.S. Department 0.340786 tobacco-specific nitrosamines 0.373338 tobacco fertilizer 0.451995 advisory committee 0.346137 powdered tobacco 0.462627 Health Organization International 0.342988 oral cancer 0.332186 National Institutes 0.343448 Watson C. Surveillance 0.3381 Tobacco Control Monograph 0.451686 moist snuff 0.436686 precancerous white patches 0.344838 International Agency 0.339252 NCI’s Smoking 0.334129 Tobacco Research 0.437462 NCI fact sheet 0.385333 lower lip 0.34967 esophageal cancer 0.332063	nicotine stays 0.353085 Yes. All tobacco 0.450832 National Cancer Institute 0.373261 LiveHelp online chat 0.341688 American snuff 0.346643 polynuclear aromatic hydrocarbons 0.347124 Eastern time 0.340428 spitting tobacco 0.470917 online text chat 0.340605 polycyclic aromatic hydrocarbons 0.346589 smokeless tobacco products 0.615213 smokeless tobacco cause 0.576883 Nicotine content 0.350271 un-ionized nicotine 0.348074 Surgeon General 0.344959 smokeless tobacco 0.995709 Yes. Smokeless tobacco 0.55885 dry snuff 0.363969 noncancerous oral conditions 0.343638 NIH State-of-the-Science Panel 0.338818 tobacco cause cancer 0.483342 smoking cessation counselor 0.38611 tobacco juices 0.469352 harmful chemicals 0.350583	CLICK HERE
1388	National Cancer Institute	Html	en	Neuroblastoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood neuroblastoma.	neuroblastoma 0.976116 childhood cancer neuroblastoma 0.551793 major familial neuroblastoma 0.521543 neuroblastoma progression 0.496843 unresectable/disseminated neuroblastoma 0.495818 Neuroblastoma Study Group 0.537536 intermediate-risk neuroblastoma patients 0.580486 neuroblastoma molecular diagnostics 0.511987 hereditary neuroblastoma 0.561905 intermediate-risk neuroblastoma group 0.584332 low-risk neuroblastoma susceptibility 0.521417 neuroblastoma identifies chromothripsis 0.508284 neuroblastoma risk group 0.724371 low-risk neuroblastoma 0.617352 High-risk neuroblastoma tumors 0.54129 high-risk neuroblastoma 0.745428 neuroblastoma section 0.536455 neuroblastoma SNP association 0.525331 stage IV-S neuroblastoma 0.494981 neuroblastoma cell 0.546055 Neuroblastoma Pathology Committee 0.5037 et al. 0.867573 Neuroblastoma Pathology Classification 0.578039 neuroblastoma tumors 0.563844 stage iv neuroblastoma 0.527215	diagnostic neuroblastoma samples. 0.552115 international neuroblastoma 0.731336 international neuroblastoma staging 0.561855 neuroblastoma cases 0.533897 PUBMED Abstract 0.580731 multifocal neuroblastoma 0.525099 neuroblastoma cells 0.534711 aggressive MYC-driven neuroblastoma 0.504084 Pediatr Blood Cancer 0.580995 Oncology Group study 0.606704 Italian Neuroblastoma group 0.510786 international neuroblastoma risk 0.640282 high-risk neuroblastoma group 0.601822 intermediate-risk neuroblastoma 0.586941 International Neuroblastoma Pathology 0.642606 childhood neuroblastoma 0.512977 Abstract 0.706617 Clin Oncol 0.827663 low-risk neuroblastoma group 0.586425 Neuroblastoma Susceptibility Locus 0.517512 heterogeneous MYCN-amplified neuroblastoma 0.505216 neuroblastoma oncogene 0.499459 metastatic neuroblastoma 0.519613 oncology group 0.651154	CLICK HERE
1524	National Cancer Institute	Html	en	Endometrial Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of endometrial cancer.	cancer treatment 0.541916 Lymph node dissection 0.478324 metastatic endometrial cancer 0.510561 body 0.511838 PDQ cancer information 0.531329 clinical trial search 0.465384 uterus 0.585793 endometrial cancer spreads 0.509404 mTOR inhibitors 0.464666 clinical trials 0.736061 cancer information summary 0.508345 clinical trial 0.5843 Low-risk endometrial cancer 0.501844 breast cancer patients 0.483969 patients 0.494506 NCI PDQ cancer 0.479485 malignant tumor cells 0.467809 lymph nodes 0.52827 endometrial hyperplasia 0.468477 radiation therapy 0.605187 Treatment Editorial Board 0.469208 endometrial cancer 0.889926 radical hysterectomy 0.471844 treatment 0.622425 cancer prevention 0.463817	new cancer treatments 0.470535 NCI-supported cancer 0.463476 cancer cells 0.753566 Cancer Information Service 0.471559 specific cancer cells 0.479989 treatment clinical trials 0.48357 High-risk endometrial cancer 0.500552 endometrial tissue 0.464689 National Cancer Institute 0.508844 new treatment 0.504217 cervix 0.474629 external radiation therapy 0.482834 non-polyposis colon cancer 0.477796 tissue samples 0.463584 cancer research process 0.465542 cancer clinical trials 0.501833 stage 0.522219 Endometrial Cancer Treatment 0.516218 Recurrent endometrial cancer 0.629078 fallopian tubes 0.494755 cancer information summaries 0.469865 treatment options 0.466033 comprehensive cancer information 0.469896 internal radiation therapy 0.504839	CLICK HERE
1552	National Cancer Institute	Html	en	Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Patient Version	Childhood ALL is a type of cancer in which the bone marrow makes too many immature lymphocytes (a type of white blood cell). Here’s what you need to know about the risk factors, signs, tests to diagnose, and treatment of newly diagnosed and recurrent ALL in this expert-reviewed summary.	red blood cells 0.416225 cancer treatment 0.28631 chemotherapy 0.431874 treatments 0.247489 PDQ cancer information 0.278302 clinical trial search 0.311111 white blood cells 0.50903 children 0.34365 systemic chemotherapy 0.367092 higher doses 0.258659 mature blood cells 0.277223 Natural killer cells 0.232346 cancer information summary 0.242631 clinical trial 0.414978 stem cells 0.325781 stem cell transplant 0.490178 Lymphoblastic Leukemia Treatment 0.242048 blood cells 0.556083 intrathecal chemotherapy 0.289545 radiation therapy 0.442509 General information 0.218828 child 0.225345 treatment 0.73359 immature blood cells 0.228445 NCI-supported cancer 0.228604	cancer cells 0.364563 remission induction 0.378898 anticancer drugs 0.454791 specific cancer cells 0.244448 acute lymphocytic leukemia 0.228943 certain changes 0.25566 treatment clinical trials 0.245143 blood stem cells 0.262182 National Cancer Institute 0.245665 spinal cord 0.639894 ) cells. 0.915202 new treatment 0.267478 consolidation /intensification 0.293759 childhood 0.307766 clinical trials 0.932686 combination chemotherapy 0.358378 maintenance phases 0.246634 brain 0.275475 bone marrow 0.619374 Philadelphia chromosome 0.248781 cancer clinical trials 0.319159 acute lymphoblastic leukemia 0.930995 cancer 0.710977 information 0.309067	CLICK HERE
1636	National Cancer Institute	Html	en	Cartilage (Bovine and Shark) (PDQ®)–Patient Version	Expert-reviewed information summary about the use of bovine and shark cartilage as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	cancer treatment 0.483107 human cancer cells 0.399726 cartilage treatment 0.54785 shark cartilage 0.911115 PDQ cancer information 0.489648 Cancer Complementary 0.397259 lung cancer 0.396037 new blood vessels 0.529873 blood vessel growth 0.688109 clinical trials 0.661965 testing bovine cartilage 0.553086 powdered cartilage products 0.528871 bovine cartilage 0.754583 cancer information summary 0.450971 clinical trial 0.545778 patients 0.414137 randomized clinical trial 0.405563 NCI PDQ cancer 0.409125 cancer information database 0.395004 liquid shark cartilage 0.530016 liquid cartilage products 0.569642 powdered shark cartilage 0.613657 cancer information 0.501779 breast cancer cells 0.394321	shark cartilage products 0.633195 laboratory study 0.408409 cartilage products 0.782377 Complementary Therapies Editorial 0.405419 cancer cells 0.530307 Cancer Information Service 0.450397 preclinical studies 0.47111 cartilage product AE–941/Neovastat 0.510074 dietary supplements 0.394341 National Cancer Institute 0.540172 studies 0.47228 alternative medicine 0.440784 pancreatic cancer cells 0.3965 human cartilage 0.495387 PDQ Cartilage 0.50056 shark cartilage product 0.665863 cartilage 0.96677 animal studies 0.448189 standard cancer treatment 0.405448 alternative therapies 0.399716 cancer information summaries 0.395389 powdered cartilage 0.59313 bovine cartilage product 0.523261 cancer 0.811115	CLICK HERE
1927	National Cancer Institute	Html	es	Tratamiento del linfoma de Hodgkin infantil (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del linfoma de Hodgkin infantil.	siguientes procedimientos 0.539535 células madre 0.949818 estadio iv 0.500925 adultos jóvenes 0.452563 órgano cercano.ampliar linfoma 0.561365 siguientes elementos 0.448931 sudores nocturnos 0.484622 faja ajustadora 0.430459 siguientes especialistas 0.43177 siguientes tipos 0.443725 vía oral 0.419326 rayos x 0.473568 Hodgkin Lymphoma 0.582459 abdomen).ampliar linfoma 0.535694 detecte.ampliar exploración 0.434601 enlace drugs approved 0.498183 escáner tep 0.492453 niño ayuda 0.424524 estadio iiies 0.760474 riesgo intermedio 0.462626 efectos tardíos 0.664689 estadio ie 0.575058 células anormales.ampliar aspiración 0.485872	PDQ Efectos tardíos 0.461638 National Cancer Institute 0.420283 sustancia quizás 0.427861 siguientes lugares 0.433237 siguientes riesgos 0.418851 Instituto Nacional 0.434896 PDQ Tratamiento 0.682769 estadio iie 0.500587 Hodgkin recién 0.557678 explorador tep 0.443167 estadio e 0.45134 nuevos tipos 0.421275 Physician Data Query 0.471298 posibles efectos 0.420063 infancia quizás 0.428464 estadio iiis 0.959473 ósea fabrica glóbulos 0.493208 pelvis.ampliar imágenes 0.420331 distinta intensidad 0.419212 almacena células 0.485736 siguientes pruebas 0.485604 siguientes estadios 0.440037	CLICK HERE
1933	National Cancer Institute	Html	es	Tratamiento del cáncer de seno (mama) en el embarazo (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de cáncer de seno (mama) en el embarazo.	estadio lllC 0.545921 procedimientos quizás 0.519027 estadio iv 0.622294 siguientes aspectos 0.528664 secciones llamadas lóbulos 0.542754 estadio lllB 0.547235 estadio lllA 0.548629 estadios ia 0.51696 ganglio linfático centinela 0.983407 Oncotype DX 0.522717 rayos x 0.518956 estadio ib 0.594193 prueba ayuda 0.551927 estadio ia 0.593122 pezón afección 0.529911 enlace drugs approved 0.522117 mama.ampliar cirugía 0.515861 causó hinchazón 0.517244 National Cancer Institute 0.51629 cuántos genes 0.520169	siguientes riesgos 0.513473 realidad células 0.541214 Instituto Nacional 0.528985 cuáles lesiones 0.51826 estadio iiia 0.547361 PDQ Tratamiento 0.523188 estadio iiic 0.745067 cáncer.ampliar mamografía 0.525478 estadio iia 0.550898 estadio llB 0.548944 estadio llA 0.550289 cuánta proteína 0.522295 siguientes casos 0.520535 Physician Data Query 0.558856 carcinoma lobulillar 0.602006 siguientes partes 0.548502 Breast Cancer 0.511799 mamas.ampliar carcinoma lobulillar 0.536157 siguientes pruebas 0.564002 vasos sanguíneos 0.630183	CLICK HERE
1959	National Cancer Institute	Html	es	Tratamiento del cáncer de vagina (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de vagina.	parto).ampliar anatomía 0.303951 siguientes procedimientos 0.324612 siguientes aspectos 0.303939 pequeña cantidad 0.302401 estadio ii 0.3299 vía oral 0.301938 historial médico 0.303531 rayos x 0.302933 estadio ivb 0.318379 intensa luz 0.302127 Pap.Ampliar Prueba 0.303248 estadio iva 0.313191 National Cancer Institute 0.301226 realidad células 0.307398 vagina causa efectos 0.315579	sangrado anormal 0.312233 áreas anormales.ampliar examen 0.305435 Instituto Nacional 0.302424 PDQ Tratamiento 0.308282 presente sección 0.301728 Physician Data Query 0.305028 medicamento des 0.324421 prueba pap 0.303798 estadio iii 0.307024 pequeña incisión 0.302169 cuello uterino 0.962189 histerectomía abdominal 0.303006 procedimiento.ampliar ureteroscopía 0.30314 siguientes estadios 0.303001	CLICK HERE
2078	National Cancer Institute	Html	es	Tomografía computarizada (TC) y exploraciones para cáncer	Hoja informativa sobre el procedimiento y tecnología de la TC y sus usos para examen de detección, diagnóstico y tratamiento del cáncer. Hoja informativa 5.2s del Instituto Nacional del Cáncer.	imágenes llamada fdg 0.212869 hallazgos anómalos 0.149049 Pediatric Computed Tomography 0.196499 persona promedio 0.156787 Retrieved July 0.224181 rayos x 0.774234 from ct scans 0.197405 ACR Appropriateness Criteria® 0.187415 Patient Safety 0.146744 Low Levels 0.215439 Radiation Risks from 0.30681 radiation dose 0.305638 health care providers 0.311726 Lung Screening Trial 0.175719 risks from 0.542401 Assess Health Risks 0.201898 Retrieved June 0.147049 Exposición Innecesaria 0.154118 Internal Medicine 0.215735 Estados Unidos 0.457591 PubMed Abstract 0.688591 from ct 0.241742 mejores imágenes 0.190153 Cancer Imaging Program 0.180886 SEER Cancer Statistics 0.179794	Reducing Radiation from 0.255009 New Hampshire Avenue 0.163654 radiation risks 0.481539 alto riesgo 0.166125 Drug Administration 0.216737 British Medical Journal 0.160951 retrospective cohort study 0.171194 Mi Historia Médica 0.162596 lifetime attributable risk 0.182458 American College 0.194044 National Cancer Institute 0.177442 Health Risks from 0.371263 baja dosis 0.918737 dosis anual promedio 0.421854 from diagnostic imaging 0.192917 arteriopatía coronaria 0.148972 computed tomography 0.455191 Ionizing Radiation 0.294632 risks from exposure 0.389205 National Research Council 0.163031 pequeños riesgos 0.152571 Colegio Americano 0.296344 Estudio Nacional 0.328775 Sociedad Radiológica 0.211562	CLICK HERE
2114	National Cancer Institute	Html	es	Exámenes de detección del cáncer de hígado (hepatocelular) (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de hígado (hepatocelular).	hepatitis c 0.799278 PDQ Exámenes 0.723065 estudio marcadores 0.652784 siguientes efectos 0.659695 Physician Data Query 0.826748 Estados Unidos 0.932003 rayos x 0.659043 prevención revisa 0.639071 sustancias dañinas 0.671115	cuerpo usa 0.666699 ondas sonoras 0.6623 siguientes exámenes 0.740755 información ayuda 0.645281 National Cancer Institute 0.657644 siguientes riesgos 0.650336 siguientes sumarios 0.743208 Instituto Nacional 0.706872 múltiples funciones 0.667669	CLICK HERE